Skip to main content
Smart Investors Daily
Sysmex Corporation logo

OTC · SSMXY

Sysmex Corporation

Healthcare · Medical - Instruments & Supplies

$12.16

Up+$0.03 (+0.25%)

Updated Oct 31, 2026, 3:39 AM

SID Score

6.5/10

Composite research score

Smart Money

46/100

Neutral

Market cap
5.95B
P/E ratio
19.61
Dividend yield
1.82%
52-week range
$8.01 – $13.01
Volume
1.14M
Avg. volume
332.32K

Price performance · SSMXY

SSMXY price history

1M range · 19 trading sessions · Daily adjusted prices

Prices through Oct 28, 2026

SSMXY closed at $12.10 after 19 trading sessions, up 4.94% for the selected period.

Last close
$12.10
Period change
+4.94%
Period low
$11.50
Period high
$12.46
Daily close
View OHLC price history
SSMXY OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 28, 2026$12.25$12.47$12.00$12.101.14M
Oct 27, 2026$12.26$12.35$12.23$12.28745.02K
Oct 26, 2026$12.30$12.49$12.30$12.4419.37K
Oct 23, 2026$12.4285$12.438$12.29$12.34125.48K
Oct 22, 2026$13.01$13.01$12.33$12.458306.51K
Oct 21, 2026$12.21$12.40$12.21$12.3925.96K
Oct 20, 2026$11.8385$11.8385$11.6679$11.821.19M
Oct 19, 2026$11.565$11.565$11.35$11.4982998.94K
Oct 16, 2026$11.73$11.73$11.5275$11.671.5M
Oct 15, 2026$11.72$11.72$11.51$11.60591.08K
Oct 14, 2026$11.48$11.5592$11.35$11.53366.22K
Oct 13, 2026$11.7975$11.7975$11.55$11.777518.23K
Oct 12, 2026$11.6145$11.75$11.57$11.7219.89K
Oct 9, 2026$11.8215$11.885$11.725$11.75312.25K
Oct 8, 2026$11.89$11.92$11.81$11.83373.76K
Oct 7, 2026$12.0895$12.0895$11.87$11.9363352.15K
Oct 6, 2026$12.0255$12.0255$11.80$11.91312.88K
Oct 5, 2026$11.15$11.6465$11.15$11.60423.53K
Oct 2, 2026$11.52$11.55$11.50$11.53630.54K

Latest SSMXY news

The latest Smart Investors Daily articles mentioning SSMXY.

SSMXY research

Overview

Company profile and research snapshot.

Company profile

SYSMEX CORP UNSP/ASDR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 10, 2026

Sysmex (TSE:6869) Stock May Be A Bargain On Cash Flow

Sysmex has put investors through a long, grinding stretch, with the share price falling 57.8% over the past 5 years. The obvious question now is whether the current ¥1,855 level is properly backed by the cash the business can generate. With the focus squarely on its cash flows, the valuation story turns on what the present share price implies about the money that can be returned to shareholders over time. A drop of 57.8% across 5 years puts the spotlight on whether Sysmex's current valuation...

Yahoo · Sep 16, 2026

Point of Care Diagnostics Market Forecasts Growth from $20.63B (2026) to $31.46B by 2031, Profiling QuidelOrtho, Sysmex, HemoCue, Trinity Biotech & 15 Other Key Players

The global point-of-care diagnostics market is projected to grow from USD 20.63 billion in 2026 to USD 31.46 billion by 2031, at an 8.8% CAGR. Growth is driven by demand for rapid, accurate and decentralized testing, alongside advances in molecular diagnostics, microfluidics, multiplex assays and portable analyzers. Biochemistry holds the largest technology share, while molecular diagnostics and infectious disease testing are set for strong growth. Clinical laboratories lead by end user, and Nor

Yahoo · Sep 14, 2026

VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in the Human Space.

By Steven Ralston, CFA NYSE: VNRX READ THE FULL VNRX RESEARCH REPORT EXECUTIVE OVERVIEW VolitionRx Limited (NYSE: VNRX) continues to advance its multi-pillar epigenetics platform through mid-2026, generating a continued stream of clinical validation across Nu.Q NETs, Nu.Q Cancer, and Capture-Seq. Management has simultaneously decreased operating expenses, which were reduced in the most recent

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.